MX2011000754A - Pirazinonas como moduladores de la actividad del receptor del factor liberador de corticotropina. - Google Patents

Pirazinonas como moduladores de la actividad del receptor del factor liberador de corticotropina.

Info

Publication number
MX2011000754A
MX2011000754A MX2011000754A MX2011000754A MX2011000754A MX 2011000754 A MX2011000754 A MX 2011000754A MX 2011000754 A MX2011000754 A MX 2011000754A MX 2011000754 A MX2011000754 A MX 2011000754A MX 2011000754 A MX2011000754 A MX 2011000754A
Authority
MX
Mexico
Prior art keywords
cyclopropyl
added
crf
difluoromethoxy
methoxyethyl
Prior art date
Application number
MX2011000754A
Other languages
English (en)
Spanish (es)
Inventor
Joanne J Bronson
Vivekananda M Vrudhula
Richard A Hartz
Vijay T Ahuja
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of MX2011000754A publication Critical patent/MX2011000754A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2011000754A 2008-07-31 2009-04-27 Pirazinonas como moduladores de la actividad del receptor del factor liberador de corticotropina. MX2011000754A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8523008P 2008-07-31 2008-07-31
PCT/US2009/041793 WO2010014280A1 (en) 2008-07-31 2009-04-27 Pyrazinone modulator of corticotropin-releasing factor receptor activity

Publications (1)

Publication Number Publication Date
MX2011000754A true MX2011000754A (es) 2011-02-24

Family

ID=40651774

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011000754A MX2011000754A (es) 2008-07-31 2009-04-27 Pirazinonas como moduladores de la actividad del receptor del factor liberador de corticotropina.

Country Status (10)

Country Link
US (2) US7932256B2 (cg-RX-API-DMAC7.html)
EP (1) EP2303867B1 (cg-RX-API-DMAC7.html)
JP (1) JP5396474B2 (cg-RX-API-DMAC7.html)
KR (1) KR20110040870A (cg-RX-API-DMAC7.html)
CN (1) CN102171205B (cg-RX-API-DMAC7.html)
AR (1) AR072639A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009277057A1 (cg-RX-API-DMAC7.html)
MX (1) MX2011000754A (cg-RX-API-DMAC7.html)
TW (1) TW201008926A (cg-RX-API-DMAC7.html)
WO (1) WO2010014280A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CA2889044A1 (en) 2012-11-15 2014-05-22 Roche Innovation Center Copenhagen A/S Anti apob antisense conjugate compounds
CA2893801A1 (en) 2013-01-30 2014-08-07 F. Hoffmann-La Roche Ag Lna oligonucleotide carbohydrate conjugates
KR20210064407A (ko) 2014-01-21 2021-06-02 뉴로크린 바이오사이언시즈 인코퍼레이티드 선천성 부신 과형성 치료를 위한 crf1 수용체 길항제
PL3984523T3 (pl) 2018-12-07 2026-02-02 Neurocrine Biosciences, Inc. Antagonista receptora crf1, jego formulacje farmaceutyczne i postacie stałe do leczenia wrodzonego przerostu nadnerczy
US12383536B2 (en) 2019-09-27 2025-08-12 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods of use
IT201900021216A1 (it) 2019-11-14 2021-05-14 Isagro Spa Processo per la preparazione di derivati piridinici e corrispondenti piridil-formammidine
ES3039926T3 (en) 2019-12-04 2025-10-27 Neurocrine Biosciences Inc Crf receptor antagonists and methods of use
CN112552184B (zh) * 2020-12-18 2022-05-10 诚达药业股份有限公司 一种含环丙基手性胺盐酸盐的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4270297A (en) * 1996-09-16 1998-04-02 Du Pont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
ATE307121T1 (de) * 2000-02-16 2005-11-15 Neurogen Corp Substituierte arylpyrazine
HRP20031096A2 (en) * 2001-06-12 2005-08-31 Neurogen Corporation 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
AU2003278542A1 (en) 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc Pyrazine compounds as crf modulators

Also Published As

Publication number Publication date
TW201008926A (en) 2010-03-01
WO2010014280A1 (en) 2010-02-04
EP2303867B1 (en) 2014-12-17
US8372847B2 (en) 2013-02-12
JP2011529886A (ja) 2011-12-15
CN102171205B (zh) 2013-08-07
US20110166160A1 (en) 2011-07-07
AR072639A1 (es) 2010-09-08
US7932256B2 (en) 2011-04-26
JP5396474B2 (ja) 2014-01-22
AU2009277057A1 (en) 2010-02-04
CN102171205A (zh) 2011-08-31
US20100029684A1 (en) 2010-02-04
KR20110040870A (ko) 2011-04-20
EP2303867A1 (en) 2011-04-06

Similar Documents

Publication Publication Date Title
JP7297871B2 (ja) Ptpn11の置換されたヘテロ環式インヒビター
DE60218037T2 (de) Neue indolderivate mit affinität zum 5-ht6-rezeptor
JP5656874B2 (ja) Pde9阻害剤として使用されるアミノヘテロ環化合物
CN103038229B (zh) 杂芳基化合物及其使用方法
JP6553629B2 (ja) 線維芽細胞増殖因子受容体阻害剤としてのキノロン誘導体
US9676758B2 (en) 1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto
US8372847B2 (en) Pyrazinone modulator of corticotropin-releasing factor receptor activity
JP2019069966A (ja) Cnsおよび他の障害を治療するための、pde4アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物
JP4318744B2 (ja) シクロペンタピリジンおよびテトラヒドロキノリン誘導体
CN102762570A (zh) 作为jak抑制剂的吡唑衍生物
JP2019523233A (ja) ムスカリン性アセチルコリンレセプターm4のポジティブアロステリック調節因子
TW202140422A (zh) 囊腫纖維化症跨膜傳導調節蛋白之調節劑
CZ20033431A3 (en) 5-ht receptor ligands and uses thereof
KR20200103760A (ko) Parp14 억제제로서의 퀴나졸리논
TW201712013A (zh) 三環化合物
JP6661605B2 (ja) 6,7−ジヒドロピラゾロ[1,5−a]ピラジン−4(5H)−オン化合物およびMGLUR2受容体の負のアロステリック調節因子としてのそれらの使用
JP2023554282A (ja) 置換ピペリジノ化合物及び関連する治療方法
CN105085482B (zh) 取代的哌嗪化合物及其使用方法和用途
DE60220385T2 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
JP6425717B2 (ja) ガンマセクレターゼモジュレーターとしての新規二環式ピリジノン
CN101652367A (zh) 作为5-ht2c激动剂的嘧啶并[4,5-d]氮杂卓衍生物
WO2024102784A1 (en) Substituted quinolinone-8-carbonitrile derivatives having androgen degradation activity and uses thereof
AU2020350211A1 (en) MLL1 inhibitors and anti-cancer agents
EP4540248A2 (en) Multi-cyclic irak and flt3 inhibiting compounds and uses thereof
KR20200060404A (ko) 신규한 염

Legal Events

Date Code Title Description
FG Grant or registration